<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="retinoschisis" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">retinoschisis</book-part-id>
      <title-group>
        <title>X-Linked Juvenile Retinoschisis</title>
        <alt-title alt-title-type="alt-title">Synonyms: Juvenile Retinoschisis, X-Linked Retinoschisis</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Sieving</surname>
            <given-names>Paul A</given-names>
          </name>
          <xref ref-type="aff" rid="retinoschisis.AFF1"/>
          <degrees>MD, PhD</degrees>
          <email>paulsieving@nei.nih.gov</email>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>MacDonald</surname>
            <given-names>Ian M</given-names>
          </name>
          <xref ref-type="aff" rid="retinoschisis.AFF2"/>
          <degrees>MD, CM</degrees>
          <email>macdonal@ualberta.ca</email>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Chan</surname>
            <given-names>Stephanie</given-names>
          </name>
          <xref ref-type="aff" rid="retinoschisis.AFF3"/>
          <degrees>MSc</degrees>
          <email>stephanie.chan@albertahealthservices.ca</email>
        </contrib>
      </contrib-group>
      <aff id="retinoschisis.AFF1">Director, National Eye Institute<break/>National Institutes of Health<break/>Bethesda, Maryland</aff>
      <aff id="retinoschisis.AFF2">Professor, Department of Ophthalmology and Visual Sciences<break/>University of Alberta<break/>Royal Alexandra Hospital<break/>Edmonton, Alberta, Canada</aff>
      <aff id="retinoschisis.AFF3">Genetic Counsellor, Department of Ophthalmology and Visual Sciences<break/>Royal Alexandra Hospital<break/>Edmonton, Alberta, Canada</aff>
      <pub-history>
        <date iso-8601-date="2003-10-24" date-type="created">
          <day>24</day>
          <month>10</month>
          <year>2003</year>
        </date>
        <date iso-8601-date="2014-08-28" date-type="updated">
          <day>28</day>
          <month>8</month>
          <year>2014</year>
        </date>
        <date iso-8601-date="2007-06-18" date-type="revised">
          <day>18</day>
          <month>06</month>
          <year>2007</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="rickets-xlh" document-type="chapter">X-Linked Hypophosphatemia</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="opitz" document-type="chapter">X-Linked Opitz G/BBB Syndrome</related-object>
      <abstract id="retinoschisis.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>X-linked juvenile retinoschisis is characterized by symmetric bilateral macular involvement with onset in the first decade of life, in some cases as early as age three months. Fundus examination shows areas of schisis (splitting of the nerve fiber layer of the retina) in the macula, sometimes giving the impression of a spoke wheel pattern. Schisis of the peripheral retina, predominantly inferotemporally, occurs in approximately 50% of individuals. Affected males typically have vision of 20/60 to 20/120. Visual acuity often deteriorates during the first and second decades of life but then remains relatively stable until the fifth or sixth decade. </p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of X-linked juvenile retinoschisis is based on fundus findings, results of electrophysiologic testing, and molecular genetic testing. <italic toggle="yes">RS1</italic> is the only gene known to be associated with X-linked juvenile retinoschisis. </p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Low-vision aids such as large-print textbooks; preferential seating in the front of the classroom; and use of handouts with high contrast. Surgery may be required to address the infrequent complications of vitreous hemorrhage and full-thickness retinal detachment. </p>
          <p><italic toggle="yes">Prevention of secondary complications</italic>: Ambylopia prevention therapy is indicated following surgical intervention for vitreous hemorrhage or retinal detachment or in cases of severe retinoschisis or hypermetropia.</p>
          <p><italic toggle="yes">Surveillance</italic>: Annual evaluation of children under age ten years by a pediatric ophthalmologist or retina specialist; patient education and close follow up may allow for early identification and treatment of vision-threatening complications.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Head trauma and high-contact sports to reduce risk of retinal detachment and vitreous hemorrhage.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>X-linked juvenile retinoschisis is inherited in an X-linked manner. Carrier women have a 50% chance of transmitting the pathogenic variant in each pregnancy: males who inherit the pathogenic variant will be affected; females who inherit the pathogenic variant will be carriers and will nearly always have normal visual function and electrophysiology. Affected males pass the pathogenic variant to all of their daughters and none of their sons. Carrier testing for at-risk female relatives and prenatal testing for pregnancies at increased risk are possible if the pathogenic variant in the family is known. </p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="retinoschisis.Diagnosis">
        <title>Diagnosis</title>
        <p><bold>Affected males.</bold> The diagnosis of X-linked juvenile retinoschisis is made in a young male with the following findings: </p>
        <list list-type="bullet">
          <list-item>
            <p>Bilaterally reduced visual acuity, typically between 20/60 and 20/120 </p>
          </list-item>
          <list-item>
            <p>The following findings on fundus examination: </p>
            <list list-type="bullet">
              <list-item>
                <p>Areas of schisis (splitting of the nerve fiber layer of the retina) in the macula, sometimes giving the impression of a spoke wheel pattern (<xref ref-type="fig" rid="retinoschisis.F1">Figure 1</xref>). </p>
              </list-item>
              <list-item>
                <p>Schisis of the peripheral retina, predominantly inferotemporally, in approximately 50% of individuals [<xref ref-type="bibr" rid="retinoschisis.REF.eksandh.2000.1098">Eksandh et al 2000</xref>]. The associated elevation of the surface layer of the retina into the vitreous has been described as "vitreous veils" (<xref ref-type="fig" rid="retinoschisis.F2">Figure 2</xref>). </p>
              </list-item>
              <list-item>
                <p>On occasion, more severe involvement of the macula (<xref ref-type="fig" rid="retinoschisis.F3">Figure 3</xref>)</p>
              </list-item>
              <list-item>
                <p>On occasion, the Mizuo phenomenon, a color change in the retina after dark adaptation with the onset of light </p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>Spectral domain optical coherence tomography (SD-OCT) that reveals characteristic signs, such as foveal schisis and thinning of the retina. This is currently the major diagnostic technique for X-linked juvenile retinoschisis [<xref ref-type="bibr" rid="retinoschisis.REF.molday.2012.195">Molday et al 2012</xref>]</p>
          </list-item>
          <list-item>
            <p>Increased fundus autofluorescence in the fovea, although this should be confirmed by SD-OCT [<xref ref-type="bibr" rid="retinoschisis.REF.renner.2008.97">Renner et al 2008</xref>, <xref ref-type="bibr" rid="retinoschisis.REF.molday.2012.195">Molday et al 2012</xref>] </p>
          </list-item>
          <list-item>
            <p>A family history consistent with X-linked inheritance </p>
          </list-item>
          <list-item>
            <p>A pathogenic variant in <italic toggle="yes">RS1</italic>
</p>
          </list-item>
        </list>
        <p>Note: Electroretinogram (ERG) is no longer the primary diagnostic tool used in the diagnosis of X-linked juvenile retinoschisis. While ERG can show selective reduction of the amplitude of the dark-adapted b-wave amplitude with relative preservation of the a-wave amplitude in affected males [<xref ref-type="bibr" rid="retinoschisis.REF.nakamura.2001.1553">Nakamura et al 2001</xref>], recent studies have shown that the ERG response is much more variable than previously thought [<xref ref-type="bibr" rid="retinoschisis.REF.molday.2012.195">Molday et al 2012</xref>]. Individuals with X-linked juvenile retinoschisis and an identified <italic toggle="yes">RS1</italic> pathogenic variant can have a technically normal ERG in which the b-wave is still present [<xref ref-type="bibr" rid="retinoschisis.REF.sieving.1999a.179">Sieving et al 1999a</xref>, <xref ref-type="bibr" rid="retinoschisis.REF.eksandh.2005.111">Eksandh et al 2005</xref>, <xref ref-type="bibr" rid="retinoschisis.REF.renner.2008.97">Renner et al 2008</xref>]. Therefore, this diagnosis cannot be excluded based on a normal ERG. </p>
        <p><bold>Carrier females.</bold> In most cases, carrier females cannot be identified by clinical examination. Carrier females nearly always have normal visual function and a normal ERG. Rarely, examination of the peripheral retina may show white flecks or areas of schisis. </p>
        <list list-type="bullet">
          <list-item>
            <p>In a study of nine obligate carriers, two had areas of retinal dysfunction detected by multifocal ERG testing. Both had normal-appearing fundi [<xref ref-type="bibr" rid="retinoschisis.REF.kim.2007.21">Kim et al 2007</xref>].</p>
          </list-item>
          <list-item>
            <p>An Australian study [<xref ref-type="bibr" rid="retinoschisis.REF.lamey.2010.283">Lamey et al 2010</xref>] identified an obligate carrier female with abnormal rod ERG and multifocal ERG. The authors attribute this finding to either skewed X-inactivation or another underlying condition. </p>
          </list-item>
        </list>
        <sec id="retinoschisis.PreliminaryTests">
          <title>PreliminaryTests</title>
          <p><bold>Intravenous fluorescein angiogram</bold> appears normal in younger individuals, whereas older individuals may have atrophic changes in the retinal pigment epithelium (RPE). </p>
          <p><bold>Optical coherence tomography (OCT)</bold> shows small cystic-appearing spaces in the perifoveal region and larger cystic-like spaces within the fovea in most school-age individuals [<xref ref-type="bibr" rid="retinoschisis.REF.apushkin.2005.612">Apushkin et al 2005</xref>]. Cystic spaces are not as evident after adolescence. OCT scans of older individuals may appear normal because of flattening of cysts with age.</p>
        </sec>
        <sec id="retinoschisis.Molecular_Genetic_Testing">
          <title>Molecular Genetic Testing</title>
          <p><bold>Gene.</bold>
<italic toggle="yes">RS1</italic> is the only gene in which pathogenic variants are known to cause X-linked juvenile retinoschisis.</p>
          <table-wrap id="retinoschisis.T.summary_of_molecular_gen" position="anchor" orientation="portrait">
            <label>Table 1.</label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in X-Linked Juvenile Retinoschisis</p>
            </caption>
            <table>
              <tbody>
                <tr>
                  <th id="hd_b_retinoschisis.T.summary_of_molecular_gen_1_1_1_1" align="left" valign="middle" rowspan="2" colspan="1" headers="hd_b_retinoschisis.T.summary_of_molecular_gen_1_1_1_1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_b_retinoschisis.T.summary_of_molecular_gen_1_1_1_2" align="left" valign="middle" rowspan="2" colspan="1" headers="hd_b_retinoschisis.T.summary_of_molecular_gen_1_1_1_2">Test Method</th>
                  <th id="hd_b_retinoschisis.T.summary_of_molecular_gen_1_1_1_3" colspan="2" align="left" valign="middle" rowspan="1">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th>
                </tr>
                <tr>
                  <th headers="hd_b_retinoschisis.T.summary_of_molecular_gen_1_1_1_3" id="hd_b_retinoschisis.T.summary_of_molecular_gen_1_1_2_1" align="left" valign="middle" rowspan="1" colspan="1">Affected Males</th>
                  <th headers="hd_b_retinoschisis.T.summary_of_molecular_gen_1_1_1_3" id="hd_b_retinoschisis.T.summary_of_molecular_gen_1_1_2_2" align="left" valign="middle" rowspan="1" colspan="1">Carrier Females</th>
                </tr>
                <tr>
                  <td headers="hd_b_retinoschisis.T.summary_of_molecular_gen_1_1_1_1" align="left" valign="middle" rowspan="4" colspan="1">
                    <italic toggle="yes">RS1</italic>
                  </td>
                  <td headers="hd_b_retinoschisis.T.summary_of_molecular_gen_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Targeted mutation analysis&#x000a0;<sup>2,&#x000a0;3</sup></td>
                  <td headers="hd_b_retinoschisis.T.summary_of_molecular_gen_1_1_1_3 hd_b_retinoschisis.T.summary_of_molecular_gen_1_1_2_1" align="left" valign="middle" rowspan="1" colspan="1">~95%&#x000a0;<sup>4</sup></td>
                  <td headers="hd_b_retinoschisis.T.summary_of_molecular_gen_1_1_1_3 hd_b_retinoschisis.T.summary_of_molecular_gen_1_1_2_2" align="left" valign="middle" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_b_retinoschisis.T.summary_of_molecular_gen_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Sequence analysis for sequence variants&#x000a0;<sup>5</sup></td>
                  <td headers="hd_b_retinoschisis.T.summary_of_molecular_gen_1_1_1_3 hd_b_retinoschisis.T.summary_of_molecular_gen_1_1_2_1" align="left" valign="middle" rowspan="1" colspan="1">~90%&#x000a0;<sup>6,&#x000a0;7</sup></td>
                  <td headers="hd_b_retinoschisis.T.summary_of_molecular_gen_1_1_1_3 hd_b_retinoschisis.T.summary_of_molecular_gen_1_1_2_2" align="left" valign="middle" rowspan="1" colspan="1">90%&#x000a0;<sup>8</sup></td>
                </tr>
                <tr>
                  <td headers="hd_b_retinoschisis.T.summary_of_molecular_gen_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Sequence analysis for partial- and whole-gene deletion&#x000a0;<sup>5</sup>
</td>
                  <td headers="hd_b_retinoschisis.T.summary_of_molecular_gen_1_1_1_3 hd_b_retinoschisis.T.summary_of_molecular_gen_1_1_2_1" align="left" valign="middle" rowspan="1" colspan="1">6%&#x000a0;<sup>9</sup></td>
                  <td headers="hd_b_retinoschisis.T.summary_of_molecular_gen_1_1_1_3 hd_b_retinoschisis.T.summary_of_molecular_gen_1_1_2_2" align="left" valign="middle" rowspan="1" colspan="1">0%&#x000a0;<sup>10</sup></td>
                </tr>
                <tr>
                  <td headers="hd_b_retinoschisis.T.summary_of_molecular_gen_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Deletion/duplication analysis&#x000a0;<sup>11</sup></td>
                  <td headers="hd_b_retinoschisis.T.summary_of_molecular_gen_1_1_1_3 hd_b_retinoschisis.T.summary_of_molecular_gen_1_1_2_1" align="left" valign="middle" rowspan="1" colspan="1">~6%&#x000a0;<sup>12</sup></td>
                  <td headers="hd_b_retinoschisis.T.summary_of_molecular_gen_1_1_1_3 hd_b_retinoschisis.T.summary_of_molecular_gen_1_1_2_2" align="left" valign="middle" rowspan="1" colspan="1">~6%&#x000a0;<sup>12</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="retinoschisis.TF.1">
                <label>1.</label>
                <p>See <related-object source-id="gene" document-id="retinoschisis" object-id="retinoschisis.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="retinoschisis.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene. </p>
              </fn>
              <fn id="retinoschisis.TF.1.1">
                <label>2.</label>
                <p>p.Glu72Lys, p.Gly74Val, p.Gly109Arg [<xref ref-type="bibr" rid="retinoschisis.REF.huopaniemi.1999.368">Huopaniemi et al 1999</xref>].</p>
              </fn>
              <fn id="retinoschisis.TF.1.2">
                <label>3.</label>
                <p>Pathogenic variants included in a panel may vary by laboratory.</p>
              </fn>
              <fn id="retinoschisis.TF.1.3">
                <label>4.</label>
                <p>In persons of Finnish heritage [<xref ref-type="bibr" rid="retinoschisis.REF.huopaniemi.1999.368">Huopaniemi et al 1999</xref>].</p>
              </fn>
              <fn id="retinoschisis.TF.1.4">
                <label>5.</label>
                <p>Sequence analysis detects variants that are benign, likely benign, of unknown significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exonic or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="retinoschisis.TF.1.5">
                <label>6.</label>
                <p>Lack of amplification by PCR prior to sequence analysis can suggest a putative (multi)exon or whole-gene deletion on the X chromosome in affected males; confirmation may require additional testing by deletion/duplication analysis. </p>
              </fn>
              <fn id="retinoschisis.TF.1.6">
                <label>7.</label>
                <p>
                  <xref ref-type="bibr" rid="retinoschisis.REF.sieving.1999b.451">Sieving et al [1999b]</xref>
                </p>
              </fn>
              <fn id="retinoschisis.TF.1.7">
                <label>8.</label>
                <p>Sequence analysis of genomic DNA cannot detect deletion of one or more exons or the entire X-linked gene in a heterozygous female.</p>
              </fn>
              <fn id="retinoschisis.TF.1.8">
                <label>9.</label>
                <p>Gel sizing analysis can detect putative (multi)exon and whole-gene deletions in <italic toggle="yes">RS1</italic> in affected males based on lack of amplification by PCR.</p>
              </fn>
              <fn id="retinoschisis.TF.1.9">
                <label>10.</label>
                <p>Sequence analysis of genomic DNA cannot detect deletion of one or more exons in <italic toggle="yes">RS1</italic> in females.</p>
              </fn>
              <fn id="retinoschisis.TF.1.10">
                <label>11.</label>
                <p>Testing that identifies exonic or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
              <fn id="retinoschisis.TF.1.11">
                <label>12.</label>
                <p>
                  <xref ref-type="bibr" rid="retinoschisis.REF.theretinosch.1998.1185">The Retinoschisis Consortium [1998]</xref>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="retinoschisis.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>Confirming the diagnosis in a proband.</bold> In general, the diagnosis in a proband can be made by ophthalmologic examination and confirmed by spectral domain optical coherence tomography. </p>
          <p>To identify the pathogenic variant in an affected male: </p>
          <p><bold>One genetic testing strategy</bold> is molecular genetic testing of <italic toggle="yes">RS1</italic>.</p>
          <list list-type="order">
            <list-item>
              <label>1</label>
              <p>In males of Finnish heritage, perform targeted mutation analysis of the three common pathogenic variants. </p>
            </list-item>
            <list-item>
              <label>2</label>
              <p>If the pathogenic variant is not identified, or for males of non-Finnish heritage, perform sequence analysis of <italic toggle="yes">RS1</italic>. </p>
            </list-item>
            <list-item>
              <label>3</label>
              <p>In males in whom a pathogenic variant is not identified by sequence analysis, consider deletion/duplication analysis of <italic toggle="yes">RS1</italic>. </p>
            </list-item>
          </list>
          <p><bold>An alternative genetic testing strategy</bold> is use of a multi-gene panel that includes <italic toggle="yes">RS1</italic> and other genes of interest (see <xref ref-type="sec" rid="retinoschisis.Differential_Diagnosis">Differential Diagnosis</xref>). Note: The genes included and the methods used in multi-gene panels vary by laboratory and over time.</p>
        </sec>
      </sec>
      <sec id="retinoschisis.Clinical_Description">
        <title>Clinical Characteristics</title>
        <sec id="retinoschisis.Natural_History">
          <title>Clinical Description</title>
          <p>X-linked juvenile retinoschisis is a symmetric bilateral macular disorder with onset in the first decade of life, in some cases as early as age three months. Affected males generally present with reduction in vision by early elementary school. Affected males typically have vision of 20/60 to 20/120 on first presentation. </p>
          <p>Visual acuity may deteriorate during the first and second decades of life but then remain relatively stable, with only very slowly progressive reduction from macular atrophy, until the fifth or sixth decade [<xref ref-type="bibr" rid="retinoschisis.REF.eksandh.2000.1098">Eksandh et al 2000</xref>, <xref ref-type="bibr" rid="retinoschisis.REF.apushkin.2005.612">Apushkin et al 2005</xref>]. Visual loss may progress to legal blindness (acuity &#x0003c;20/200) by the sixth or seventh decade. In individuals over age 50 years, macular pigmentary changes and some degree of atrophy of the RPE are common. The delayed B-wave onset seen in a study of 68 affected males suggests that photoreceptor synapse or bipolar cell dysfunction increases with age [<xref ref-type="bibr" rid="retinoschisis.REF.bowles.2011.9250">Bowles et al 2011</xref>]. </p>
          <p>Variation in disease presentation and disease progression is observed even among members of the same family.</p>
          <p>Appearance of foveal lesions varies from largely radial striations (3%), microcystic lesions (34%), honeycomb-like cysts (8%), or their combinations (31%) to non-cystic-appearing foveal changes including pigment mottling (8%), loss of the foveal reflex (8%), or an atrophic-appearing lesion (8%) [<xref ref-type="bibr" rid="retinoschisis.REF.apushkin.2005.612">Apushkin et al 2005</xref>].</p>
          <p>X-linked juvenile retinoschisis progresses to retinal detachment in an estimated 5% to 22% of affected individuals. Retinal detachment can occur in infants with severe retinoschisis. About 4% to 40% of individuals with X-linked juvenile retinoschisis develop vitreous hemorrhage.</p>
        </sec>
        <sec id="retinoschisis.GenotypePhenotype_Correlat">
          <title>Genotype-Phenotype Correlations</title>
          <p>Missense, splice site, frameshift, insertion, and deletion mutations all result in the same phenotype. Some studies suggest that pathogenic variants that putatively cause protein truncation result in greater clinical severity [<xref ref-type="bibr" rid="retinoschisis.REF.sieving.1999b.451">Sieving et al 1999b</xref>]. </p>
          <p>The possibility of meaningful genotype-phenotype correlations in X-linked juvenile retinoschisis is debated. On one hand, there can be variable phenotypic expression between siblings, other related individuals, and non-related individuals sharing the same pathogenic variant. However, milder phenotypic abnormalities are more commonly seen in males with missense pathogenic variants. This may be due to residual <italic toggle="yes">RS1</italic> gene expression in such affected males compared to those with other types of pathogenic variants. Other as-yet unidentified factors are likely involved as well [<xref ref-type="bibr" rid="retinoschisis.REF.kim.2013.392">Kim &#x00026; Mukai 2013</xref>]. </p>
        </sec>
        <sec id="retinoschisis.Penetrance">
          <title>Penetrance</title>
          <p>X-linked juvenile retinoschisis exhibits complete penetrance with variable expressivity. </p>
        </sec>
        <sec id="retinoschisis.Nomenclature">
          <title>Nomenclature</title>
          <p>Other terms correctly used in the past to refer to X-linked juvenile retinoschisis:</p>
          <list list-type="bullet">
            <list-item>
              <p>Juvenile retinoschisis </p>
            </list-item>
            <list-item>
              <p>Congenital retinoschisis </p>
            </list-item>
            <list-item>
              <p>Juvenile macular degeneration/dystrophy </p>
            </list-item>
            <list-item>
              <p>Degenerative retinoschisis</p>
            </list-item>
          </list>
          <p>Other terms incorrectly used in the past to refer to X-linked juvenile retinoschisis:</p>
          <list list-type="bullet">
            <list-item>
              <p>Cone dystrophy </p>
            </list-item>
            <list-item>
              <p>Macular hole </p>
            </list-item>
          </list>
        </sec>
        <sec id="retinoschisis.Prevalence">
          <title>Prevalence</title>
          <p>Estimates of the prevalence of X-linked juvenile retinoschisis vary from one in 5,000 to one in 25,000 [<xref ref-type="bibr" rid="retinoschisis.REF.theretinosch.1998.1185">The Retinoschisis Consortium 1998</xref>].</p>
        </sec>
      </sec>
      <sec id="retinoschisis.Genetically_Related_Alleli">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with mutation of <italic toggle="yes">RS1</italic>.</p>
      </sec>
      <sec id="retinoschisis.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>While the presence of retinoschisis in an individual with a positive family history of X-linked juvenile retinoschisis establishes the diagnosis in that person, making the diagnosis in a male with no known family history may be more difficult.</p>
        <p><bold>Cystoid macular edema</bold> may mimic foveal retinoschisis. Macular edema may be caused by diabetes mellitus, inflammatory conditions of the eye (uveitis), or intraocular surgery. </p>
        <p><bold>Amblyopia</bold> can be a referring diagnosis when foveal schisis changes are subtle. Suspicion of X-linked juvenile retinoschisis is raised if family history indicates other affected males in an X-linked inheritance pattern. </p>
        <p><bold>Goldmann-Favre vitreoretinal degeneration and enhanced S-cone syndrome</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/268100">268100</ext-link>)<bold>,</bold> caused by pathogenic variants in <italic toggle="yes">NR2E3,</italic> may mimic X-linked juvenile retinoschisis. Onset occurs in infancy. Generally, affected individuals have severely impaired vision including marked visual field loss and severe night blindness. Coarse intraretinal cysts may be seen with peripheral retinoschisis; no vitreous veils are observed. The electroretinogram shows markedly reduced a-waves and b-waves with altered timing rather than simply the reduction in the b-wave amplitude found in X-linked juvenile retinoschisis. Inheritance is autosomal recessive.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="rp-overview" document-type="chapter"><bold>Retinitis pigmentosa</bold></related-object>
<bold>(RP)</bold> is the referring diagnosis in many persons with X-linked juvenile retinoschisis. Characteristics of RP that distinguish it from X-linked juvenile retinoschisis include some or all of the following: optic nerve gliotic pallor, narrowing of retinal vessels, and intraretinal pigment dispersion or clumping. The X-linked form of RP may cause confusion with X-linked juvenile retinoschisis, and other family members should be examined; the ERG in RP (particularly X-linked RP) is markedly diminished rather than having the selective reduction in b-wave amplitude seen in X-linked juvenile retinoschisis. <xref ref-type="bibr" rid="retinoschisis.REF.noble.1978.551">Noble et al [1978]</xref> reported a family with rod-cone dystrophy and associated foveal schisis. For this reason, foveal retinoschisis alone does not make the diagnosis of X-linked juvenile retinoschisis. </p>
        <p><related-object link-type="booklink" source-id="gene" document-id="wagner" document-type="chapter"><bold><italic toggle="yes">VCAN</italic>-related vitreoretinopathy</bold></related-object>, which includes <bold>Wagner syndrome</bold> and <bold>erosive vitreoretinopathy (ERVR),</bold> is characterized by &#x0201c;optically empty vitreous&#x0201d; on slit-lamp examination and avascular vitreous strands and veils, mild or occasionally moderate to severe myopia, presenile cataract, night blindness of variable degree associated with progressive chorioretinal atrophy, retinal traction and retinal detachment at advanced stages of the disease, and reduced visual acuity. Optic nerve inversion has also been described. The first signs usually become apparent during early adolescence but onset can be as early as age two years. Pathogenic variants in <italic toggle="yes">VCAN</italic> (previously <italic toggle="yes">CSPG2</italic>) are causative. Inheritance is autosomal dominant.</p>
        <p><bold>Degenerative retinoschisis</bold> is an idiopathic, degenerative disease of the peripheral retina. No evidence suggests genetic etiology [<xref ref-type="bibr" rid="retinoschisis.REF.lewis.2003.155">Lewis 2003</xref>]. In degenerative or age-related peripheral retinoschisis, splitting occurs in the outer retina through the outer nuclear layer and plexiform layer, whereas in X-linked juvenile retinoschisis, splitting is found in the nerve fiber layer and the ganglion cell layer [<xref ref-type="bibr" rid="retinoschisis.REF.sieving.1998.1">Sieving 1998</xref>]. </p>
        <p><bold>Retinal detachment,</bold> in which the full-thickness retina elevates and lifts off from the underlying ocular support, differs from retinoschisis, in which the retina splits through the nerve fiber layer. Retinal detachment in an otherwise normal eye can be surgically repaired, whereas retinal detachment associated with retinoschisis usually cannot. </p>
      </sec>
      <sec id="retinoschisis.Management">
        <title>Management</title>
        <sec id="retinoschisis.Evaluations_Following_Init">
          <title>Evaluations Following Initial Diagnosis </title>
          <p>To establish the extent of disease and needs in an individual diagnosed with X-linked juvenile retinoschisis, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Visual acuity</p>
            </list-item>
            <list-item>
              <p>Goldmann visual field</p>
            </list-item>
            <list-item>
              <p>Family history</p>
            </list-item>
            <list-item>
              <p>Electroretinogram</p>
            </list-item>
            <list-item>
              <p>Funduscopic examination</p>
            </list-item>
            <list-item>
              <p>Optical coherence tomography</p>
            </list-item>
            <list-item>
              <p>Genetic counseling</p>
            </list-item>
          </list>
        </sec>
        <sec id="retinoschisis.Treatment_of_Manifestation">
          <title>Treatment of Manifestations</title>
          <p>Low-vision services are designed to benefit those whose ability to function is compromised by vision impairment. Low-vision specialists, often optometrists, help optimize the use of remaining vision. Services provided vary based on age and needs.</p>
          <p>Public school systems are mandated by federal law to provide appropriate education for children who have vision impairment. Assistance may include larger print textbooks, preferential seating in the front of the classroom, and use of handouts with higher contrast.</p>
          <p>Many individuals with X-linked juvenile retinoschisis are able to obtain a restricted driver's license. Some individuals have found specially designed telescopic lenses useful when driving; legal use of telescopic lenses may vary by locale.</p>
          <p>Retinoschisis affects primarily the inner retinal layers; hence, retinoschisis alone (without retinal detachment) is at best difficult to treat surgically. </p>
          <p>Treatment of retinoschisis may require the care of a retinal surgeon to address the infrequent complications of vitreous hemorrhage and full-thickness retinal detachment. The clinical presentation of a large area of peripheral retinoschisis may mask a true retinal detachment. Advice from an ophthalmologist or retinal surgeon should be sought when in doubt.</p>
        </sec>
        <sec id="retinoschisis.Prevention_of_Secondary_Co">
          <title>Prevention of Secondary Complications</title>
          <p>Ambylopia prevention therapy is indicated following surgical intervention to treat vitreous hemorrhage or retinal detachment, or in cases of severe retinoschisis or hypermetropia [<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://emedicine.medscape.com/article/1225857-treatment">Medscape</ext-link>, accessed 8-21-14].</p>
        </sec>
        <sec id="retinoschisis.Surveillance">
          <title>Surveillance</title>
          <p>Annual evaluation of children under age ten years by a pediatric ophthalmologist or retina specialist is recommended.</p>
          <p>Patient education and close follow-up are the only clinical options that may allow for early identification and treatment of vision-threatening complications [<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&#x00026;data_id=155&#x00026;MISSING%20CONTENT=X-linked-retinoschisis&#x00026;title=X-linked-retinoschisis&#x00026;search=Disease_Search_Simple">Orphanet</ext-link>, accessed 8-21-14]. </p>
          <p>Older children and adults need less frequent monitoring.</p>
        </sec>
        <sec id="retinoschisis.AgentsCircumstances_to_Avo">
          <title>Agents/Circumstances to Avoid</title>
          <p>Although retinal detachment and vitreous hemorrhage occur in a minority of affected individuals (5%-22% and 4%-40%, respectively), general avoidance of head trauma and high-contact sports is recommended.</p>
        </sec>
        <sec id="retinoschisis.Evaluation_of_Relatives_at">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to evaluate at-risk male relatives of an affected individual in order to identify as early as possible those who would benefit from institution of treatment and preventive measures. </p>
          <list list-type="bullet">
            <list-item>
              <p>If the <italic toggle="yes">RS1</italic> pathogenic variant in the family is known, molecular genetic testing can be used to clarify the genetic status of at-risk relatives.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant in the family is not known, examination by an ophthalmologist can be used to clarify the affected status of at-risk relatives for early treatment of retinal detachment.</p>
            </list-item>
          </list>
          <p>See <xref ref-type="sec" rid="retinoschisis.Related_Genetic_Counseling">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="retinoschisis.Therapies_Under_Investigat">
          <title>Therapies Under Investigation</title>
          <p>A mouse model of human X-linked juvenile retinoschisis was studied to determine whether supplementation with functional normal retinoschisin protein can produce improvement in ERG function and retina morphology [<xref ref-type="bibr" rid="retinoschisis.REF.zeng.2004.3279">Zeng et al 2004</xref>, <xref ref-type="bibr" rid="retinoschisis.REF.min.2005.644">Min et al 2005</xref>]. Subsequent evaluation of the mouse model confirmed that it appropriately mimics structural features of human X-linked juvenile retinoschisis. Replacements of the deficient protein through use of a neomycin resistance cassette or through use of an AAV vector were both successful, suggesting that, with additional study, gene therapy could become a viable strategy for therapeutic intervention [<xref ref-type="bibr" rid="retinoschisis.REF.kjellstrom.2007.3837">Kjellstrom et al 2007</xref>]. </p>
          <p>Other researchers showed that older mice had significantly reduced benefit from AAV <italic toggle="yes">Rs1h</italic> cDNA (the mouse ortholog of human <italic toggle="yes">RS1</italic>) gene transfer compared to younger mice that had rescue of retinal structure and function. These benefits along with retinoschisin expression persisted for over 15 months. Other studies showed that intravitreal injection of a rAAV8 vector containing the mouse <italic toggle="yes">Rs1h</italic> cDNA under the control of a human retinoschisin promoter in <italic toggle="yes">Rs1h</italic> knockout mice yielded strong retinoschisin expression and structural and functional improvements. Wildtype retinoschisin delivered and expressed in human retinal culture cells has been shown to undergo protein folding, subunit assembly, and secretion mostly independent of endogenously expressed, defective retinoschisin protein. This suggests that gene therapy could be possible for affected individuals who have residual, pathogenic RS1 protein expression [<xref ref-type="bibr" rid="retinoschisis.REF.molday.2012.195">Molday et al 2012</xref>]. </p>
          <p><xref ref-type="bibr" rid="retinoschisis.REF.byrne.2014.585">Byrne et al [2014]</xref> explained that cell targeting and appropriate vector choice are very important to the success of retinal gene therapy. This group demonstrated that different cell types were able to secrete retinoschisin, transporting the protein across the retina. Photoreceptor cell secretion of this protein produced the best long-term rescue. </p>
          <p>Another therapeutic approach involves in vivo directed evolution of AAV variants to deliver the wildtype gene to the outer retina after injection to the vitreous humor of the eye. The authors suggested that this has the potential to be a broadly applicable gene delivery method for inherited retinal diseases [<xref ref-type="bibr" rid="retinoschisis.REF.dalkara.2013.1">Dalkara et al 2013</xref>]. </p>
          <p>Possible drawbacks of using viral vectors (e.g., the risks of oncogenicity, immunogenicity, and the possible persistence of such vectors in the brain after intravitreal injection) have triggered an interest in non-viral systems. A combination of solid lipid nanoparticles, dextran, and protamine as well as EGFP and RS1 plasmids have been used to develop non-viral vectors for X-linked juvenile retinoschisis treatment. Researchers studied the in vitro transfection capacity, cellular uptake, and intracellular trafficking of these vectors in ARPE-19 cells. In vivo intravitreal, subretinal, and topical forms of vector administration in Wistar rat eyes were also evaluated. EGFP expression in various cell types depended on the administration route. This work suggests that these non-viral vectors may be useful in treating X-linked juvenile retinoschisis, other degenerative retinal diseases, and ocular surface diseases as well [<xref ref-type="bibr" rid="retinoschisis.REF.delgado.2012.345">Delgado et al 2012</xref>]. </p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="retinoschisis.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="retinoschisis.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>X-linked juvenile retinoschisis is inherited in an X-linked recessive manner. </p>
        </sec>
        <sec id="retinoschisis.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p><bold>Parents of a proband</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>The father of an affected male will neither have the disease nor be a carrier of the <italic toggle="yes">RS1</italic> pathogenic variant. </p>
            </list-item>
            <list-item>
              <p>In a family with more than one affected individual, the mother of an affected male is an obligate carrier. Note: If a woman has more than one affected son and no other affected relatives and the pathogenic variant cannot be detected in her leukocyte DNA, she has germline mosaicism. </p>
            </list-item>
            <list-item>
              <p>Obligate carriers do not exhibit any signs in the macula, and only rarely are peripheral retinal changes associated with the carrier state. </p>
            </list-item>
            <list-item>
              <p>If a male is the only affected family member (i.e., a simplex case), the mother may be a carrier or the affected male may have a <italic toggle="yes">de novo RS1</italic> mutation (in which case the mother is not a carrier). <italic toggle="yes">De novo</italic> mutations have been reported but are rare [<xref ref-type="bibr" rid="retinoschisis.REF.gehrig.1999.932">Gehrig et al 1999</xref>].</p>
            </list-item>
            <list-item>
              <p>When an affected male represents a simplex case, several possibilities regarding his mother's carrier status need to be considered: </p>
              <list list-type="bullet">
                <list-item>
                  <p>He has a <italic toggle="yes">de novo</italic> pathogenic variant in <italic toggle="yes">RS1</italic> and his mother is not a carrier. </p>
                </list-item>
                <list-item>
                  <p>His mother has a <italic toggle="yes">de novo</italic> pathogenic variant in <italic toggle="yes">RS1</italic>, either (a) as a "germline mutation" (i.e., present at the time of her conception and therefore present in every cell of her body); or (b) as "germline mosaicism" (i.e., present in some of her germ cells only). </p>
                </list-item>
                <list-item>
                  <p>His mother has a pathogenic variant that she inherited from a maternal female ancestor. </p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p><bold>Sibs of a proband</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to sibs depends on the carrier status of the mother. </p>
            </list-item>
            <list-item>
              <p>If the mother is a carrier, the chance of transmitting the <italic toggle="yes">RS1</italic> pathogenic variant in each pregnancy is 50%. Male sibs who inherit the pathogenic variant will be affected; female sibs who inherit the pathogenic variant will be carriers. Carriers nearly always have normal visual function and normal electrophysiology (i.e., ERG). </p>
            </list-item>
            <list-item>
              <p>If the mother is not a carrier, the risk to sibs is low but may be higher than that of the general population (the risk of germline mosaicism in mothers is not known). </p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Males will pass the pathogenic variant to all of their daughters and none of their sons. </p>
          <p><bold>Other family members of a proband.</bold> The proband's maternal aunts may be at risk of being carriers and the aunt's offspring, depending on their gender, may be at risk of being carriers or of being affected. </p>
          <p>Note: Molecular genetic testing may be able to identify the family member in whom a <italic toggle="yes">de novo</italic> pathogenic variant arose, information that could help determine genetic risk status of the extended family.</p>
        </sec>
        <sec id="retinoschisis.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Carrier testing for at-risk females requires prior identification of the pathogenic variant in the family.</p>
        </sec>
        <sec id="retinoschisis.Related_Genetic_Counseling">
          <title>Related Genetic Counseling Issues</title>
          <p>See <xref ref-type="sec" rid="retinoschisis.Evaluation_of_Relatives_at">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p><bold>Family planning</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy. </p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals. </p>
        </sec>
        <sec id="retinoschisis.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>If the <italic toggle="yes">RS1</italic> pathogenic variant has been identified in an affected family member, prenatal testing for pregnancies at increased risk may be available from a clinical laboratory that offers either testing of this gene or custom prenatal testing. </p>
          <p>Requests for prenatal testing for conditions such as X-linked juvenile retinoschisis are not common. Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the <italic toggle="yes">RS1</italic> pathogenic variant has been identified. </p>
        </sec>
      </sec>
      <sec id="retinoschisis.Resources">
        <title>Resources</title>
      </sec>
      <sec id="retinoschisis.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="retinoschisis.Molecular_Genetic_Pathogen">
          <title>Molecular Genetic Pathogenesis</title>
          <p>For many years, X-linked juvenile retinoschisis has been thought of as a possible defect in the Muller cell, acting as a cellular scaffold within the retinal architecture. Studies on gene expression and immunolocalization of the normal protein, retinoschisin, indicate that it is expressed within the photoreceptors and has a complex interaction within cells of the retina. Retinoschisin is most highly expressed in the inner segments of the photoreceptors in human eye sections [<xref ref-type="bibr" rid="retinoschisis.REF.mooy.2002.979">Mooy et al 2002</xref>] and other mammals including mice [<xref ref-type="bibr" rid="retinoschisis.REF.molday.2001.816">Molday et al 2001</xref>]. The protein was secreted by differentiated <related-object link-type="booklink" source-id="gene" document-id="retinoblastoma" document-type="chapter">retinoblastoma</related-object> cells (Weri-Rb1) [<xref ref-type="bibr" rid="retinoschisis.REF.grayson.2000.1873">Grayson et al 2000</xref>]. From expression studies, it remains unclear whether the protein product of mutant disease-causing alleles is secreted properly [<xref ref-type="bibr" rid="retinoschisis.REF.wang.2002.3097">Wang et al 2002</xref>, <xref ref-type="bibr" rid="retinoschisis.REF.wu.2003.28139">Wu &#x00026; Molday 2003</xref>].</p>
          <p>In studying the mouse model of retinoschisis created by gene knockout, <xref ref-type="bibr" rid="retinoschisis.REF.weber.2002.6222">Weber et al [2002]</xref> noted disruption of the normal retinal cellular organization and the appearance of schisis-like cavities in the inner retina. The electroretinogram showed selective reduction of the ERG b-wave and a severe effect on the cone ERG. Atypical photoreceptor synapses were also observed, implicating a role for retinoschisin in the normal maintenance of the photoreceptor-bipolar synapse. </p>
          <p><bold>Gene structure.</bold> The transcript is 3040 bp in length <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000330.3">NM_000330.3</ext-link>) and comprises six exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="retinoschisis" object-id="retinoschisis.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Benign allelic variants.</bold> A comprehensive list of benign allelic variants (sequence polymorphisms) is maintained through the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.dmd.nl/rs">RetinoschisisDB<sup>&#x000a9;</sup></ext-link> of the Retinoschisis Consortium. </p>
          <p><bold>Pathogenic allelic variants.</bold> More than 196 pathogenic variants in <italic toggle="yes">RS1</italic> have been associated with X-linked juvenile retinoschisis [<xref ref-type="bibr" rid="retinoschisis.REF.kim.2013.392">Kim &#x00026; Mukai 2013</xref>]. Most pathogenic variants occur in the discoidin domain of <italic toggle="yes">RS1</italic>, exons 4-6. An up-to-date listing of these pathogenic variants is maintained by the Retinoschisis Consortium; see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.dmd.nl/rs">RetinoschisisDB<sup>&#x000a9;</sup></ext-link>. </p>
          <p><bold>Normal gene product.</bold> Retinoschisin is a 224-amino acid protein (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000321.1">NP_000321.1</ext-link>). Retinoschisin is an extracellular protein that exists as a novel disulfide-linked octamer. While it is expected to play a crucial role in cellular organization of the retina, the function of retinoschisin is as yet unknown [<xref ref-type="bibr" rid="retinoschisis.REF.wu.2005.10721">Wu et al 2005</xref>]. </p>
          <p><bold>Abnormal gene product.</bold> The abnormal gene product may be sequestered in the cell and degraded or secreted [<xref ref-type="bibr" rid="retinoschisis.REF.wang.2002.3097">Wang et al 2002</xref>, <xref ref-type="bibr" rid="retinoschisis.REF.wu.2003.28139">Wu &#x00026; Molday 2003</xref>].</p>
        </sec>
      </sec>
      <sec id="retinoschisis.References">
        <title>References</title>
        <sec id="retinoschisis.Published_GuidelinesConsen">
          <title>Published Guidelines/Consensus Statements</title>
          <p>AAO Task Force on Genetic Testing. American Academy of Ophthalmology Recommendations for 2014 genetic testing guidelines. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://one.aao.org/clinical-statement/recommendations-genetic-testing-of-inherited-eye-d">online</ext-link>. 2014. Accessed 8-22-14.</p>
        </sec>
        <sec id="retinoschisis.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="retinoschisis.Literature_Cited.reflist0">
            <ref id="retinoschisis.REF.apushkin.2005.612">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Apushkin</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fishman</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajagopalan</surname>
                    <given-names>AS</given-names>
                  </name>
                </person-group>
                <article-title>Fundus findings and longitudinal study of visual acuity loss in patients with X-linked retinoschisis.</article-title>
                <source>Retina</source>
                <year>2005</year>
                <volume>25</volume>
                <fpage>612</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16077359</pub-id>
              </element-citation>
            </ref>
            <ref id="retinoschisis.REF.bowles.2011.9250">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bowles</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cukras</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turriff</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sergeev</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vitale</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bush</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sieving</surname>
                    <given-names>PA</given-names>
                  </name>
                </person-group>
                <article-title>X-linked retinoschisis: RS1 mutation severity and age affect the ERG phenotype in a cohort of 68 affected male subjects.</article-title>
                <source>Invest Ophthalmol Vis Sci.</source>
                <year>2011</year>
                <volume>52</volume>
                <fpage>9250</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">22039241</pub-id>
              </element-citation>
            </ref>
            <ref id="retinoschisis.REF.byrne.2014.585">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Byrne</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozt&#x000fc;rk</surname>
                    <given-names>BE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fortuny</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Visel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalkara</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaffer</surname>
                    <given-names>DV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flannery</surname>
                    <given-names>JG</given-names>
                  </name>
                </person-group>
                <article-title>Retinoschisin gene therapy in photoreceptors, M&#x000fc;ller glia or all retinal cells in the Rs1h-/- mouse.</article-title>
                <source>Gene Ther.</source>
                <year>2014</year>
                <volume>21</volume>
                <fpage>585</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">24694538</pub-id>
              </element-citation>
            </ref>
            <ref id="retinoschisis.REF.dalkara.2013.1">
              <mixed-citation publication-type="book">Dalkara D, Byrne LC, Klimczak RR, Visel M, Yin L, Merigan WH, Flannery JG, Schaffer DV. In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous. Sci Transl Med. 2013;5:189ra76. </mixed-citation>
            </ref>
            <ref id="retinoschisis.REF.delgado.2012.345">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Delgado</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>del Pozo-Rodr&#x000ed;guez</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Solin&#x000ed;s</surname>
                    <given-names>M&#x000c1;</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Avil&#x000e9;s-Triqueros</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fern&#x000e1;ndez</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasc&#x000f3;n</surname>
                    <given-names>AR</given-names>
                  </name>
                </person-group>
                <article-title>Dextran and protamine-based solid lipid nanoparticles as potential vectors for the treatment of X-linked juvenile retinoschisis.</article-title>
                <source>Hum Gene Ther.</source>
                <year>2012</year>
                <volume>23</volume>
                <fpage>345</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">22295905</pub-id>
              </element-citation>
            </ref>
            <ref id="retinoschisis.REF.eksandh.2005.111">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Eksandh</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andr&#x000e9;asson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abrahamson</surname>
                    <given-names>M.</given-names>
                  </name>
                </person-group>
                <article-title>Juvenile X-linked retinoschisis with normal scotopic b-wave in the electroretinogram at an early stage of the disease.</article-title>
                <source>Ophthalmic Genet.</source>
                <year>2005</year>
                <volume>26</volume>
                <fpage>111</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16272055</pub-id>
              </element-citation>
            </ref>
            <ref id="retinoschisis.REF.eksandh.2000.1098">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Eksandh</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ponjavic</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ayyagari</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bingham</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hiriyanna</surname>
                    <given-names>KT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andreasson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ehinger</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sieving</surname>
                    <given-names>PA</given-names>
                  </name>
                </person-group>
                <article-title>Phenotypic expression of juvenile X-linked retinoschisis in Swedish families with different mutations in the XLRS1 gene.</article-title>
                <source>Arch Ophthalmol</source>
                <year>2000</year>
                <volume>118</volume>
                <fpage>1098</fpage>
                <lpage>104</lpage>
                <pub-id pub-id-type="pmid">10922205</pub-id>
              </element-citation>
            </ref>
            <ref id="retinoschisis.REF.gehrig.1999.932">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gehrig</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lorenz</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrassi</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>First molecular evidence for a de novo mutation in RS1 (XLRS1) associated with X linked juvenile retinoschisis.</article-title>
                <source>J Med Genet</source>
                <year>1999</year>
                <volume>36</volume>
                <fpage>932</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">10636740</pub-id>
              </element-citation>
            </ref>
            <ref id="retinoschisis.REF.grayson.2000.1873">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Grayson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reid</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellis</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rutherford</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sowden</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yates</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farber</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trump</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Retinoschisin, the X-linked retinoschisis protein, is a secreted photoreceptor protein, and is expressed and released by Weri-Rb1 cells.</article-title>
                <source>Hum Mol Genet</source>
                <year>2000</year>
                <volume>9</volume>
                <fpage>1873</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10915776</pub-id>
              </element-citation>
            </ref>
            <ref id="retinoschisis.REF.huopaniemi.1999.368">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Huopaniemi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rantala</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forsius</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Somer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de la Chapelle</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alitalo</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Three widespread founder mutations contribute to high incidence of X-linked juvenile retinoschisis in Finland.</article-title>
                <source>Eur J Hum Genet</source>
                <year>1999</year>
                <volume>7</volume>
                <fpage>368</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">10234514</pub-id>
              </element-citation>
            </ref>
            <ref id="retinoschisis.REF.kim.2013.392">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>DY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mukai</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>X-linked juvenile retinoschisis (XLRS): a review of genotype-phenotype relationships.</article-title>
                <source>Semin Ophthalmol.</source>
                <year>2013</year>
                <volume>28</volume>
                <fpage>392</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">24138048</pub-id>
              </element-citation>
            </ref>
            <ref id="retinoschisis.REF.kim.2007.21">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seiple</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fishman</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szlyk</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <article-title>Multifocal ERG findings in carriers of X-linked retinoschisis.</article-title>
                <source>Doc Ophthalmol.</source>
                <year>2007</year>
                <volume>114</volume>
                <fpage>21</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">17180613</pub-id>
              </element-citation>
            </ref>
            <ref id="retinoschisis.REF.kjellstrom.2007.3837">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kjellstrom</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bush</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeng</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takada</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sieving</surname>
                    <given-names>PA</given-names>
                  </name>
                </person-group>
                <article-title>Retinoschisin gene therapy and natural history in the Rs1h-KO mouse: long-term rescue from retinal degeneration.</article-title>
                <source>Invest Ophthalmol Vis Sci</source>
                <year>2007</year>
                <volume>48</volume>
                <fpage>3837</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">17652759</pub-id>
              </element-citation>
            </ref>
            <ref id="retinoschisis.REF.lamey.2010.283">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lamey</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laurin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chelva</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Roach</surname>
                    <given-names>J.</given-names>
                  </name>
                </person-group>
                <article-title>Genotypic analysis of X-linked retinoschisis in Western Australia.</article-title>
                <source>Adv Exp Med Biol.</source>
                <year>2010</year>
                <volume>664</volume>
                <fpage>283</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">20238027</pub-id>
              </element-citation>
            </ref>
            <ref id="retinoschisis.REF.lewis.2003.155">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lewis</surname>
                    <given-names>H.</given-names>
                  </name>
                </person-group>
                <article-title>Peripheral retinal degenerations and the risk of retinal detachment.</article-title>
                <source>Am J Ophthalmol.</source>
                <year>2003</year>
                <volume>136</volume>
                <fpage>155</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">12834683</pub-id>
              </element-citation>
            </ref>
            <ref id="retinoschisis.REF.min.2005.644">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Min</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molday</surname>
                    <given-names>LL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seeliger</surname>
                    <given-names>MW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dinculescu</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmers</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janssen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonagel</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanimoto</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molday</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hauswirth</surname>
                    <given-names>WW</given-names>
                  </name>
                </person-group>
                <article-title>Prolonged recovery of retinal structure/function after gene therapy in an Rs1h-deficient mouse model of x-linked juvenile retinoschisis.</article-title>
                <source>Mol Ther</source>
                <year>2005</year>
                <volume>12</volume>
                <fpage>644</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">16027044</pub-id>
              </element-citation>
            </ref>
            <ref id="retinoschisis.REF.molday.2001.816">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Molday</surname>
                    <given-names>LL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hicks</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sauer</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molday</surname>
                    <given-names>RS</given-names>
                  </name>
                </person-group>
                <article-title>Expression of X-linked retinoschisis protein RS1 in photoreceptor and bipolar cells.</article-title>
                <source>Invest Ophthalmol Vis Sci</source>
                <year>2001</year>
                <volume>42</volume>
                <fpage>816</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">11222545</pub-id>
              </element-citation>
            </ref>
            <ref id="retinoschisis.REF.molday.2012.195">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Molday</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kellner</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>BH</given-names>
                  </name>
                </person-group>
                <article-title>X-linked juvenile retinoschisis: clinical diagnosis, genetic analysis, and molecular mechanisms.</article-title>
                <source>Prog Retin Eye Res.</source>
                <year>2012</year>
                <volume>31</volume>
                <fpage>195</fpage>
                <lpage>212</lpage>
                <pub-id pub-id-type="pmid">22245536</pub-id>
              </element-citation>
            </ref>
            <ref id="retinoschisis.REF.mooy.2002.979">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mooy</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Den Born</surname>
                    <given-names>LI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baarsma</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paridaens</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraaijenbrink</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bergen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>BH</given-names>
                  </name>
                </person-group>
                <article-title>Hereditary X-linked juvenile retinoschisis: a review of the role of M&#x000fc;ller cells.</article-title>
                <source>Arch Ophthalmol</source>
                <year>2002</year>
                <volume>120</volume>
                <fpage>979</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">12096974</pub-id>
              </element-citation>
            </ref>
            <ref id="retinoschisis.REF.nakamura.2001.1553">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terasaki</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyake</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <article-title>Japanese X-linked juvenile retinoschisis: conflict of phenotype and genotype with novel mutations in the XLRS1 gene.</article-title>
                <source>Arch Ophthalmol</source>
                <year>2001</year>
                <volume>119</volume>
                <fpage>1553</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">11594966</pub-id>
              </element-citation>
            </ref>
            <ref id="retinoschisis.REF.noble.1978.551">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Noble</surname>
                    <given-names>KG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carr</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siegel</surname>
                    <given-names>IM</given-names>
                  </name>
                </person-group>
                <article-title>Familial foveal retinoschisis associated with a rod-cone dystrophy.</article-title>
                <source>Am J Ophthalmol</source>
                <year>1978</year>
                <volume>85</volume>
                <fpage>551</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">306756</pub-id>
              </element-citation>
            </ref>
            <ref id="retinoschisis.REF.renner.2008.97">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Renner</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kellner</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fiebig</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cropp</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foerster</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>BH</given-names>
                  </name>
                </person-group>
                <article-title>ERG variability in X-linked congenital retinoschisis patients with mutations in the RS1 gene and the diagnostic importance of fundus autofluorescence and OCT.</article-title>
                <source>Doc Ophthalmol.</source>
                <year>2008</year>
                <volume>116</volume>
                <fpage>97</fpage>
                <lpage>109</lpage>
                <pub-id pub-id-type="pmid">17987333</pub-id>
              </element-citation>
            </ref>
            <ref id="retinoschisis.REF.sieving.1998.1">
              <mixed-citation publication-type="book">Sieving PA. Juvenile retinoschisis. In: Traboulsi EI, ed. <italic toggle="yes">Genetic Diseases of the Eye</italic>. New York, NY: Oxford University Press; 1998:347-55.</mixed-citation>
            </ref>
            <ref id="retinoschisis.REF.sieving.1999a.179">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sieving</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bingham</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kemp</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richards</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hiriyanna</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Juvenile X-linked retinoschisis from XLRS1 Arg213Trp mutation with preservation of the electroretinogram scotopic b-wave.</article-title>
                <source>Am J Ophthalmol</source>
                <year>1999a</year>
                <volume>128</volume>
                <fpage>179</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">10458173</pub-id>
              </element-citation>
            </ref>
            <ref id="retinoschisis.REF.sieving.1999b.451">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sieving</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yashar</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ayyagari</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Juvenile retinoschisis: a model for molecular diagnostic testing of X-linked ophthalmic disease.</article-title>
                <source>Trans Am Ophthalmol Soc</source>
                <year>1999b</year>
                <volume>97</volume>
                <fpage>451</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">10703138</pub-id>
              </element-citation>
            </ref>
            <ref id="retinoschisis.REF.theretinosch.1998.1185">
              <element-citation publication-type="journal">
                <publisher-name>The Retinoschisis Consortium</publisher-name>
                <article-title>Functional implications of the spectrum of mutations found in 234 cases with X-linked juvenile retinoschisis.</article-title>
                <source>Hum Mol Genet</source>
                <year>1998</year>
                <volume>7</volume>
                <fpage>1185</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">9618178</pub-id>
              </element-citation>
            </ref>
            <ref id="retinoschisis.REF.wang.2002.3097">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waters</surname>
                    <given-names>CT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rothman</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakins</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>R&#x000f6;misch</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trump</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Intracellular retention of mutant retinoschisin is the pathological mechanism underlying X-linked retinoschisis.</article-title>
                <source>Hum Mol Genet</source>
                <year>2002</year>
                <volume>11</volume>
                <fpage>3097</fpage>
                <lpage>105</lpage>
                <pub-id pub-id-type="pmid">12417531</pub-id>
              </element-citation>
            </ref>
            <ref id="retinoschisis.REF.weber.2002.6222">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schrewe</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molday</surname>
                    <given-names>LL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gehrig</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seeliger</surname>
                    <given-names>MW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaissle</surname>
                    <given-names>GB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedburg</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamm</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molday</surname>
                    <given-names>RS</given-names>
                  </name>
                </person-group>
                <article-title>Inactivation of the murine X-linked juvenile retinoschisis gene, Rs1h, suggests a role of retinoschisin in retinal cell layer organization and synaptic structure.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <year>2002</year>
                <volume>99</volume>
                <fpage>6222</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">11983912</pub-id>
              </element-citation>
            </ref>
            <ref id="retinoschisis.REF.wu.2003.28139">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>WW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molday</surname>
                    <given-names>RS</given-names>
                  </name>
                </person-group>
                <article-title>Defective discoidin domain structure, subunit assembly, and endoplasmic reticulum processing of retinoschisin are primary mechanisms responsible for X-linked retinoschisis.</article-title>
                <source>J Biol Chem</source>
                <year>2003</year>
                <volume>278</volume>
                <fpage>28139</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">12746437</pub-id>
              </element-citation>
            </ref>
            <ref id="retinoschisis.REF.wu.2005.10721">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>WW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kast</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molday</surname>
                    <given-names>RS</given-names>
                  </name>
                </person-group>
                <article-title>RS1, a discoidin domain-containing retinal cell adhesion protein associated with X-linked retinoschisis, exists as a novel disulfide-linked octamer.</article-title>
                <source>J Biol Chem</source>
                <year>2005</year>
                <volume>280</volume>
                <fpage>10721</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">15644328</pub-id>
              </element-citation>
            </ref>
            <ref id="retinoschisis.REF.zeng.2004.3279">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zeng</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takada</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kjellstrom</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hiriyanna</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanikawa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wawrousek</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smaoui</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caruso</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bush</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sieving</surname>
                    <given-names>PA</given-names>
                  </name>
                </person-group>
                <article-title>RS-1 gene delivery to an adult Rs1h knockout mouse model restores ERG b-wave with reversal of the electronegative waveform of X-linked retinoschisis.</article-title>
                <source>Invest Ophthalmol Vis Sci</source>
                <year>2004</year>
                <volume>45</volume>
                <fpage>3279</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">15326152</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="retinoschisis.Chapter_Notes">
        <title>Chapter Notes</title>
        <p>
          <bold>Author History</bold>
        </p>
        <p>Stephanie Chan, MSc (2014-present)Ian M MacDonald, MD, CM (2003-present)Paul A Sieving, MD, PhD (2003-present)Meira Rina Meltzer, MA, MS; National Institutes of Health (2003-2014)Nizar Smaoui, MD, FACMG; GeneDx (2003-2014)</p>
        <sec id="retinoschisis.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>28 August 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>12 May 2009 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>18 June 2007 (cd) Revision: MLPA used for carrier testing for female relatives, as current PCR methodologies detect deletions in affected males only </p>
            </list-item>
            <list-item>
              <p>18 January 2006 (me) Comprehensive update posted to live Web site </p>
            </list-item>
            <list-item>
              <p>28 June 2004 (cd) Revision: change in test availability </p>
            </list-item>
            <list-item>
              <p>24 October 2003 (me) Review posted to live Web site </p>
            </list-item>
            <list-item>
              <p>1 July 2003 (ps) Original submission </p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec id="retinoschisis.1.11" sec-type="figs-and-tables">
        <title/>
        <fig id="retinoschisis.F1" position="float" orientation="portrait">
          <label>Figure 1.</label>
          <caption>
            <p>Fundus photo of a male with juvenile retinoschisis. Arrow points to typical spoke-wheel pattern of foveal cysts.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="retinoschisisFig1" position="anchor" orientation="portrait"/>
        </fig>
        <fig id="retinoschisis.F2" position="float" orientation="portrait">
          <label>Figure 2.</label>
          <caption>
            <p>Fundus photo of the peripheral retina of a male with juvenile retinoschisis. Area marked with arrows shows a partial-thickness retinal hole.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="retinoschisisFig2" position="anchor" orientation="portrait"/>
        </fig>
        <fig id="retinoschisis.F3" position="float" orientation="portrait">
          <label>Figure 3.</label>
          <caption>
            <p>Fundus photo of a male with juvenile retinoschisis showing atypical, more severe findings with arrows pointing to atrophic macular changes</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="retinoschisisFig3" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
